Huanlei Wu
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
-
- Lung Cancer Research Studies 2
- Peptidase Inhibition and Analysis 2
-
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 2
- Cancer-related gene regulation 2
- RNA Research and Splicing 2
- Journals
- PLoS ONE (1 paper)Clinical Cancer Research (1 paper)Biomedicine & Pharmacotherapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Huanlei Wu
14 papers receiving 319 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 124
- Oncology 80
- Molecular Biology 201
- Pulmonary and Respiratory Medicine 86
- Otorhinolaryngology 7
Countries citing papers authored by Huanlei Wu
This map shows the geographic impact of Huanlei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanlei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanlei Wu more than expected).
Fields of papers citing papers by Huanlei Wu
This network shows the impact of papers produced by Huanlei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanlei Wu. The network helps show where Huanlei Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huanlei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 19 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 8 | |
| 7 | 2018 | 62 | |
| 8 | 2016 | 50 | |
| 9 | 2016 | 14 | |
| 10 | 2015 | 26 | |
| 11 | 2014 | 10 | |
| 12 | 2013 | 60 | |
| 13 | 2013 | 5 | |
| 14 | 2012 | 18 | |
| 15 | 2012 | 28 |
About Huanlei Wu
Huanlei Wu is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 15 papers that have together received 319 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), MicroRNA in disease regulation (3 papers), Lung Cancer Research Studies (2 papers), Peptidase Inhibition and Analysis (2 papers), Ubiquitin and proteasome pathways (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer-related gene regulation (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (124 citations), Oncology (80 citations) and Molecular Biology (201 citations). Huanlei Wu has collaborated with scholars based in China and United States. Frequent co-authors include Jia Hu, Yu Xiao, Shaogang Wang, Zhangqun Ye, Xianglin Yuan, Qianxia Li, Zhongxing Liao, Ju Dong Yang, Kun Tang and Bo Liu. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.